Maine is part of two multi-state lawsuits dealing with alleged medication violations.
CVS/Caremark Corp., based in Rhode Island, will pay out $36.7 million to 23 states, including Maine, as well as the District of Columbia and the federal government, to settle claims it substituted tablets of a common anti-ulcer medicine with a pricier capsule form of the drug, resulting in higher Medicaid payments, according to a press release from Pennsylvania’s attorney general’s office.
Maine also has joined 17 other states in a class-action lawsuit against drug companies Abbott Laboratories, based in Illinois, and Fournier Industrie et Sante and Laboratories Fournier SA of France for allegedly blocking generic competition for a cheaper form of their cholesterol medication TriCor, according to the Associated Press.
